A new review in Medical Oncology details how liquid biomarkers, advanced imaging, and artificial intelligence are transforming pre-biopsy discrimination of prostate cancer from benign disease.
MDPI and Research Solutions' Scite have partnered to index MDPI's open access journals for discovery through AI assistants, ...
A survey of 419 physicians in the West Bank found that fewer than half had good knowledge of infantile epileptic spasms ...
A landmark simulation and field study shows that PDC bit wear and rock lithology interact nonadditively to shape drilling ...
A UK Biobank study of 45,542 adults links biological aging, frailty, adverse environmental exposures, and plasma metabolic ...
A new review in BMC Medicine proposes that endogenous lithium deficiency worsens Alzheimer's disease by undermining cerebral ...
Researchers have assembled the first complete chloroplast genome of the Near Threatened dipterocarp Parashorea lucida, ...
A Dutch Delphi consensus study has produced the first patient-centered core outcome set for vulvar cancer, identifying 45 ...
Transportation Barriers Emerge as Strongest Predictor of Emergency Care in Landmark Safety-Net Study
A study of more than 20,000 safety-net patients in the Bronx found that transportation-related delayed care, not food ...
A prospective study of 655 women with polycystic ovary syndrome found that cumulative live birth rates plateau after eight ...
A prospective study shows PSMA PET/CT-guided targeted biopsy detects clinically significant prostate cancer in 37 percent of ...
Researchers have developed a hybrid Grey Wolf Coot Optimization routing framework with dynamic physically unclonable ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results